ifosfamide
Not Tagged
['reecur', 'sarcoma']
#reecur: the first ever phase 3 randomised high-dose #ifosfamide (ifos) vs commonly used therapy study in ewing #sarcoma discussed at #asco2022 1 med.efs 5.7 vs. 3.7 mos
2 med. os 16.8 vs 10.4 mos
3 ifos has a better efficacy in prolonging survival 
Independent & international experts in #Sarcoma. #MedEd communicators, keeping you up to date with research & medical news in Sarcoma. Part of https://t.co/qM8Tca8PQX